Mode
Text Size
Log in / Sign up
N/A Completed N=934 Randomized Prevention

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

Human Immunodeficiency Virus Infection · Acquired Immunodeficiency Syndrome · HIV · Sexually Transmitted Diseases, Viral
Source: ClinicalTrials.gov NCT04772469 ↗
Enrolled (actual)
934
Serious AEs
1.9%
Results posted
Apr 2025
Primary outcomePrimary: Self-reported HIV Testing — 65.6; 31.3 percentage of participants

Summary

This is a randomized controlled trial to test a combination behavioral and biomedical interventions to improve the HIV prevention and care cascades in a population of mobile men in a high priority setting (fishermen in Kenya). The intervention strategy is to recruit and train highly socially-connected men to distribute HIV self-tests and provide linkage support to men in their close social networks. The study will determine whether this social network-based approach along with small financial incentives in the form of transport vouchers can increase men's self-testing, linkage to and uptake of ART and PrEP after self-testing, virologic suppression at 6 months (for those initiating ART) and PrEP adherence (for those initiating PrEP) at 6 months. The study includes a longitudinal qualitative and mixed methods (quantitative and qualitative assessments) to identify the pathways of intervention action, and understand how the social network-based approach with support for linkage affects testing and ART and PrEP uptake and retention in men.

Outcome Measures

OutcomeResultp-value
PRIMARY
Self-reported HIV Testing
65.6; 31.3
PRIMARY
Percentage of Participants Who Linked to a Study-affiliated Clinic Within 3 Months
67.3; 15.6
SECONDARY
Linkage to PrEP
19.7; 19.6
SECONDARY
Adherence to PrEP (% With Detectable Tenofovir in the Urine)
18.7; 8.3
SECONDARY
Adherence to ART
35.7; 40.2

Eligibility Criteria

Inclusion Criteria

  • Adult (18 years or older)
  • Male
  • Working as a fisherman or fishing-related occupation
  • Willing and able to provide informed consent for participation
  • Not participating in another research study related to HIV testing, treatment and/or prevention

Exclusion Criteria

  • Younger than 18 years of age
  • Female
  • Included in another intervention study on HIV/AIDS
  • Inadequate cognitive and/or hearing capacity to complete planned study procedures, at the discretion of the study team
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04772469). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search